{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T05:33:16Z","timestamp":1775885596965,"version":"3.50.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This study explored the causal connection among the plasma lipidome, nonalcoholic fatty liver disease (NAFLD), and potential metabolome mediators through Mendelian randomization (MR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We obtained summary statistics for 179 plasma lipidome traits (<jats:italic>N<\/jats:italic> = 7,174), 1,400 plasma metabolome traits (<jats:italic>N<\/jats:italic> = 8,299), and one NAFLD trait from publicly available genome-wide association studies. A two-sample MR analysis was conducted to infer causality. Additionally, multiple sensitivity analyses were conducted to assess the heterogeneity, horizontal pleiotropy, and robustness of the MR findings. MetaboAnalyst 6.0 was used for the pathway analysis of the identified lipids and metabolites. Furthermore, we used mediation analysis to assess whether the effect of plasma lipidome on NAFLD was mediated by plasma metabolome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The MR analysis predicted a genetically determined causal relationship between plasma lipidomes and NAFLD. No compelling proof was found that genetically predicted NAFLD influenced the risk of the five plasma lipidomes mentioned earlier. Based on established causal relationships between lipids and metabolites, we identified that eight metabolic pathways are closely associated with NAFLD. Our mediation analysis revealed six mediation relationships, indicating the causal pathway from plasma lipids to NAFLD mediated by five specific metabolites. No potential pleiotropy was found in the sensitivity analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In summary, our study identified causal relationships between plasma lipidomes, plasma metabolomes, and NAFLD. Certainly, the impact of plasma lipidomes on NAFLD is not limited to plasma metabolomes, indicating a need to further investigate into other possible mediators. These identified factors may become new biomarkers of the NAFLD contributing to its prevention, diagnosis, and treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1436827","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T05:10:49Z","timestamp":1737609049000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of plasma metabolome in mediating the effect of plasma lipidome on NAFLD: a Mendelian randomization study"],"prefix":"10.3389","volume":"15","author":[{"given":"Zhuyuan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaojie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanlin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingnan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of nafld development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00066-3","article-title":"Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"8","author":"Tincopa","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051292","article-title":"Navigating through the lipid metabolism maze: diagnosis and prognosis metabolites of hepatocellular carcinoma versus compensated cirrhosis","volume":"11","author":"Nenu","year":"2022","journal-title":"J Clin Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154320","article-title":"The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease","author":"Perakakis","year":"2020","journal-title":"Metabolism"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in nafld: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104543","article-title":"Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease","volume":"90","author":"Li","year":"2023","journal-title":"EBioMedicine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-022-00868-3","article-title":"Lifestyle and metabolic factors for nonalcoholic fatty liver disease: mendelian randomization study","volume":"37","author":"Yuan","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1053\/j.gastro.2017.01.015","article-title":"Metabolomic identification of subtypes of nonalcoholic steatohepatitis","volume":"152","author":"Alonso","year":"2017","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e716","DOI":"10.1002\/osp4.716","article-title":"Adipose triglyceride lipase gene expression in peripheral blood mononuclear cells of subjects with obesity and its association with insulin resistance, inflammation and lipid accumulation in liver","volume":"10","author":"Ezzati-Mobaser","year":"2024","journal-title":"Obes Sci Pract"},{"key":"B12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jgg.2019.11.009","article-title":"Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression","volume":"47","author":"Wang","year":"2020","journal-title":"J Genet Genomics"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation","volume":"36","author":"Carter","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the strobe-mr statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1038\/s41467-023-42532-8","article-title":"Genome-wide association analysis of plasma lipidome identifies 495 genetic associations","volume":"14","author":"Ottensmann","year":"2023","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100437","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease","volume":"2","author":"Ghodsian","year":"2021","journal-title":"Cell Rep Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1348347","article-title":"Effect of the gut microbiome, plasma metabolome, peripheral cells, and inflammatory cytokines on obesity: A bidirectional two-sample mendelian randomization study and mediation analysis","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1054206","article-title":"Genetically predicted C-reactive protein mediates the association between rheumatoid arthritis and atlantoaxial subluxation","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.12688\/wellcomeopenres.16374.2","article-title":"Mendelianrandomization V0.5.0: updates to an R package for performing mendelian randomization analyses using summarized data","volume":"5","author":"Broadbent","year":"2020","journal-title":"Wellcome Open Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae253","article-title":"Metaboanalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation","volume":"52","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.013","article-title":"Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis","volume":"75","author":"Ooi","year":"2021","journal-title":"J Hepatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100479","article-title":"Lipid alterations in chronic liver disease and liver cancer","volume":"4","author":"Paul","year":"2022","journal-title":"JHEP Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11100694","article-title":"Contribution of metabolomics to the understanding of nafld and nash syndromes: A systematic review","volume":"11","author":"Piras","year":"2021","journal-title":"Metabolites"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-013-0590-1","article-title":"Changes in metabolite profiles caused by genetically determined obesity in mice","volume":"10","author":"Schafer","year":"2014","journal-title":"Metabolomics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e000368","DOI":"10.1136\/bmjgast-2019-000368","article-title":"Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia","volume":"7","author":"Maev","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2023.101432","article-title":"Concise review of lipidomics in nonalcoholic fatty liver disease","volume":"49","author":"Beland-Bonenfant","year":"2023","journal-title":"Diabetes Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.03.007","article-title":"The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis","volume":"3","author":"Li","year":"2006","journal-title":"Cell Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.5650\/jos.ess23167","article-title":"The regulatory mechanism of smilax China L. Saponins against nonalcoholic fatty liver is revealed by metabolomics and transcriptomics","volume":"73","author":"Li","year":"2024","journal-title":"J Oleo Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2016.10.016","article-title":"Linoleic acid causes greater weight gain than saturated fat without hypothalamic inflammation in the male mouse","volume":"40","author":"Mamounis","year":"2017","journal-title":"J Nutr Biochem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29013","article-title":"17beta-estradiol protects female rats from bilateral oophorectomy-induced nonalcoholic fatty liver disease induced by improving linoleic acid metabolism alteration and gut microbiota disturbance","volume":"10","author":"Tian","year":"2024","journal-title":"Heliyon"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051220","article-title":"Metabolomics characterizes the effects and mechanisms of quercetin in nonalcoholic fatty liver disease development","volume":"20","author":"Xu","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2023.05.012","article-title":"Eight zhes decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics, network pharmacology and pharmacokinetics","volume":"13","author":"Zhou","year":"2023","journal-title":"J Pharm Anal"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51367","article-title":"Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes","volume":"8","author":"Rumora","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202007_21912","article-title":"A targeted metabolomic profiling of plasma acylcarnitines in nonalcoholic fatty liver disease","volume":"24","author":"Chang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj125","article-title":"Caffeine metabolites in umbilical cord blood, cytochrome P-450 1a2 activity, and intrauterine growth restriction","volume":"163","author":"Grosso","year":"2006","journal-title":"Am J Epidemiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911751","article-title":"A physiologically based pharmacokinetic model to predict the impact of metabolic changes associated with metabolic associated fatty liver disease on drug exposure","volume":"23","author":"Newman","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1158\/1055-9965.EPI-19-0900","article-title":"Diet-related metabolomic signature of long-term breast cancer risk using penalized regression: an exploratory study in the su.Vi.Max cohort","volume":"29","author":"Lecuyer","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4344905","article-title":"Glucocorticosteroids and the risk of nafld in inflammatory bowel disease","volume":"2022","author":"Jarmakiewicz-Czaja","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.11.018","article-title":"Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study","volume":"60","author":"Abrigo","year":"2014","journal-title":"J Hepatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071682","article-title":"Sphingosine-1-phosphate metabolism in the regulation of obesity\/type 2 diabetes","volume":"9","author":"Guitton","year":"2020","journal-title":"Cells"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-20-0018","article-title":"Scfas alleviated steatosis and inflammation in mice with nash induced by mcd","volume":"245","author":"Deng","year":"2020","journal-title":"J Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.0c07467","article-title":"Gut microbiota and its metabolite deoxycholic acid contribute to sucralose consumption-induced nonalcoholic fatty liver disease","volume":"69","author":"Shi","year":"2021","journal-title":"J Agric Food Chem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00319.2018","article-title":"Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity","volume":"316","author":"Masuda","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e2217543120","DOI":"10.1073\/pnas.2217543120","article-title":"Inhibition of hsd17b13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis","volume":"120","author":"Luukkonen","year":"2023","journal-title":"Proc Natl Acad Sci U.S.A"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1436827\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T05:10:53Z","timestamp":1737609053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1436827\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":50,"alternative-id":["10.3389\/fendo.2024.1436827"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1436827","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"article-number":"1436827"}}